132
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

In vitro inhibition of low density lipoprotein carbamylation by vitamins, as an ameliorating atherosclerotic risk in uremic patients

&
Pages 122-127 | Received 22 Jul 2009, Accepted 30 Dec 2009, Published online: 15 Feb 2010

References

  • Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003;14:S131–8.
  • Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention. Circulation 2003;108:2154–69.
  • Kraus LM, Kraus AP Jr. Carbamylation of amino acids and proteins in uremia. Kidney Int Suppl 2001;78:S102–7.
  • Apostolov EO, Shah SV, Ok E, Basnakian AG. Quantification of carbamylated LDL in human sera by a new sandwich ELISA. Clin Chem 2005;51:719–28.
  • Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV. Carbamylated low density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int 2005;68:173–8.
  • Choy JC, Granville DJ, Hunt DW, McManus BM. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001; 33:1673–90.
  • Prior RL. Fruits and vegetables in the prevention of cellular oxidative damage. Am J Clin Nutr 2003;78:570S–8S.
  • Gieseg SP, Esterbauer H. Low density lipoprotein is saturable by pro-oxidant copper. FEBS 1994;343:188–94.
  • Ghaffari MA, Mojab S. In vitro effect of α-tocopherol, ascorbic acid and lycopene on low density lipoprotein glycation. Iran J Pharma Res 2007;6:265–71.
  • Weisgraber KH, Innerarity TL, Mahley RW. Role of lysine residues of plasma lipoprotein in high affinity binding to cell surface receptors on human fibroblasts. J Biol Chem 1978;253:9053–62.
  • Trepanier DJ, Thibert RJ, Draisey TF, Caines PS. Carbamylation of erythrocyte membrane proteins: an in vitro and in vivo study. Clin Biochem 1996;29:347–55.
  • Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 1968;9:693–700.
  • Ogden RC, Adams DA. Electrophoresis in agarose and acrylamide gels. Methods Enzymol 1987;152:61–87.
  • Bradford MM. A rapid and sensitive for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248–54.
  • Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115–26.
  • Kraus LM, Gaber L, Handorf CR, Marti HP, Kraus AP Jr. Carbamylation of glomerular and tubular proteins in patients with kidney failure: a potential mechanism of ongoing renal damage. Swiss Med Wkly 2001;131:139–45.
  • Kraus LM, Kraus AP Jr. The search for the uremic toxin: the case for carbamylation of amino acids and proteins. Wien Klin Wochenschr 1998;110:521–30.
  • Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Hörkkö S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 2007;13:1176–84.
  • Peterson CM, Tsairis P, Ohnishi A, Lu YS, Grady R. Sodium cyanate induced polyneuropathy in patients with sickle cell disease. Ann Intern Med 1974;81:152–8.
  • Nicholson DH, Harkness DR, Benson WE, Peterson CM. Cyanate-induced cataracts in patients with sickle cell hemoglobinopathies. Arch Ophthalmol 1976;94:927–30.
  • Horkko S, Huttunen K, Kervinen K, Kesaniemi YA. Decreased clearance of uraemic and mildly cabamylated low density lipoprotein. Eur J Clin Invest 1994;24:105–13.
  • Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med 2007;43:4–15.
  • Ghaffari MA, Saffari MR, Ghiasvand T. The effect of α-tocopherol on copper binding to low density lipoprotein. Iran J Pharma Res 2006;3:209–14.
  • Ghaffari MA, Ghiasvand T. Effect of lycopene on formation of low density lipoprotein copper complex in copper catalyzed peroxidation of low density lipoprotein, as in vitro experiment. Iran Biomed J 2006;10:191–6.
  • Giardini O, Taccone-Gallucci M, Lubrano R, Ricciardi-Tenore G, Bandino D, Silvi I, Ruberto U, Casciani CU. Evidence of red blood cell membrane lipid peroxidation in hemodialysis patients. Nephron 1984;36:235–7.
  • Kuroda M, Asaka S, Tofuku Y, Takeda R. Serum antioxidant activity in uremic patients. Nephron 1985;41:293–8.
  • Rissanen T, Voutilainen S, Nyyssonen K, Salonen JT. Lycopene atherosclerosis, and coronary heart disease. Exp Biol Med 2002;227:900–7.
  • Stahl W, Sies H. Antioxidant activity of carotenoids. Mol Aspects Med 2003;24:345–51.
  • Fuhrman B, Volkova N, Rosenblat M, Aviram M. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antioxid Redox Signal 2000;2:491–506.
  • Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins: vitamins E and C, beta-carotene and other carotenoids. Ann N Y Acad Sci 1992;669:7–20.
  • Frei B. Ascorbic acid protects lipids in human plasma and low density lipoprotein against oxidative damage. Am J Clin Nutr 1991;54:1113S–8S.
  • Bohm F, Edge R, Land EJ. Carotenoids enhance vitamin E antioxidant efficiency. J Am Chem Soc 1997;119:621–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.